anti-cd20 type i and type ii antibody combination therapy

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG;ROCHE GLYCART AG

发明人:

THOMAS FRIESS,CHRISTIAN KLEIN,PABLO UMANA

申请号：

BRPI0816458

公开号：

BRPI0816458A2

申请日:

2008.08.20

申请国别(地区):

BR

年份:

2013

代理人:

摘要：

COMBINED THERAPY WITH ANTI-CD2O TYPE 1 AND TYPE II ANTIBODIES. The present invention relates to the combination therapy of a type 1 and type II anti-CD20 antibody for the treatment of cancer, especially CD2O-expressing cancer.TERAPIA COMBINADA COM ANTICORPOS ANTI-CD2O TIPO 1 E TIPO II. A presente invenção refere-se à terapia combinada de um anti-corpo anti-CD2O tipo 1 e tipo II para o tratamento de câncer, especialmente de câncer que expressa CD2O.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/